Beta-cell adaptation and decompensation during the progression of diabetes
- PMID: 11272180
- DOI: 10.2337/diabetes.50.2007.s154
Beta-cell adaptation and decompensation during the progression of diabetes
Abstract
Inadequate beta-cell function is an essential component of all forms of diabetes. The most obvious problem is a failure to maintain sufficient beta-cell mass and function to cope with whatever insulin resistance is present. The most striking functional defect is a loss of acute glucose-induced insulin secretion (GIIS). This review discusses the ways in which beta-cells successfully adapt to increased demand and then decompensate as diabetes develops. Successful adaptation is achieved through increased beta-cell mass and increased insulin secretion. The hypothesis is explored that beta-cells exposed to the diabetic milieu lose their differentiation, which leads to loss of specialized functions such as GIIS. This concept has been strengthened by the finding of dedifferentiation of beta-cells in a rat model of partial pancreatectomy that includes a reduction of insulin gene expression, which may further contribute to decreased insulin production. Another finding was increased expression of c-Myc, which probably contributes to an increase in the expression of lactate dehydrogenase and the development of beta-cell hypertrophy. Arguments are developed that the beta-cell changes found in diabetes are better correlated with increased glucose levels than with non-esterified fatty acid levels, thus supporting the importance of glucose toxicity.
Similar articles
-
Five stages of evolving beta-cell dysfunction during progression to diabetes.Diabetes. 2004 Dec;53 Suppl 3:S16-21. doi: 10.2337/diabetes.53.suppl_3.s16. Diabetes. 2004. PMID: 15561905 Review.
-
[Anatomical and functional plasticity of pancreatic beta-cells and type 2 diabetes].Med Sci (Paris). 2007 Oct;23(10):885-94. doi: 10.1051/medsci/20072310885. Med Sci (Paris). 2007. PMID: 17937902 Review. French.
-
The relationship of diabetes, loss of glucose-induced insulin secretion, and GLUT2.J Diabetes Complications. 1993 Apr-Jun;7(2):124-9. doi: 10.1016/1056-8727(93)90037-y. J Diabetes Complications. 1993. PMID: 8518454 Review.
-
Evolution of beta-cell dysfunction in the male Zucker diabetic fatty rat.Diabetes. 1995 Dec;44(12):1447-57. doi: 10.2337/diab.44.12.1447. Diabetes. 1995. PMID: 7589853
-
Transcription factor abnormalities as a cause of beta cell dysfunction in diabetes: a hypothesis.Acta Diabetol. 1997 Oct;34(3):177-84. doi: 10.1007/s005920050071. Acta Diabetol. 1997. PMID: 9401638 Review.
Cited by
-
Increase of Calcium Sensing Receptor Expression Is Related to Compensatory Insulin Secretion during Aging in Mice.PLoS One. 2016 Jul 21;11(7):e0159689. doi: 10.1371/journal.pone.0159689. eCollection 2016. PLoS One. 2016. PMID: 27441644 Free PMC article.
-
Angiotensin I-converting enzyme type 2 (ACE2) gene therapy improves glycemic control in diabetic mice.Diabetes. 2010 Oct;59(10):2540-8. doi: 10.2337/db09-0782. Epub 2010 Jul 26. Diabetes. 2010. PMID: 20660625 Free PMC article.
-
Cardiac Glucolipotoxicity and Cardiovascular Outcomes.Medicina (Kaunas). 2018 Oct 11;54(5):70. doi: 10.3390/medicina54050070. Medicina (Kaunas). 2018. PMID: 30344301 Free PMC article. Review.
-
Effects of food restriction and/or aerobic exercise on the GLUT4 in type 2 diabetic male rats.Int J Prev Med. 2019 Aug 12;10:139. doi: 10.4103/ijpvm.IJPVM_383_17. eCollection 2019. Int J Prev Med. 2019. PMID: 31516680 Free PMC article.
-
Cell maturation: Hallmarks, triggers, and manipulation.Cell. 2022 Jan 20;185(2):235-249. doi: 10.1016/j.cell.2021.12.012. Epub 2022 Jan 6. Cell. 2022. PMID: 34995481 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical